Compumedics Limited (ASX:CMP)
Australia
· Delayed Price · Currency is AUD 0.305
+0.005 (1.67%)
At close: Mar 6, 2026
Compumedics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 58.28 | 50.83 | 49.72 | 42.41 | 37.76 | 35.74 | Upgrade
|
| Other Revenue | 0.21 | 0.21 | 0.54 | 0.52 | 0.85 | - | Upgrade
|
| Revenue | 58.49 | 51.04 | 50.26 | 42.92 | 38.61 | 35.74 | Upgrade
|
| Revenue Growth (YoY) | 23.46% | 1.55% | 17.10% | 11.18% | 8.02% | 1.91% | Upgrade
|
| Cost of Revenue | 27.25 | 22.91 | 23.65 | 20.82 | 18.44 | 16.58 | Upgrade
|
| Gross Profit | 31.24 | 28.13 | 26.61 | 22.11 | 20.17 | 19.16 | Upgrade
|
| Selling, General & Admin | 26.23 | 25.89 | 21.14 | 19.66 | 15.13 | 14.38 | Upgrade
|
| Research & Development | 2.41 | 1.34 | 5.74 | 5.46 | 4.06 | 4.39 | Upgrade
|
| Other Operating Expenses | -0.45 | - | - | - | - | -0.56 | Upgrade
|
| Operating Expenses | 28.18 | 27.23 | 26.88 | 25.12 | 19.18 | 18.21 | Upgrade
|
| Operating Income | 3.06 | 0.9 | -0.27 | -3.02 | 0.99 | 0.96 | Upgrade
|
| Interest Expense | -1.46 | -1.29 | -0.74 | -0.65 | -0.4 | -0.33 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.09 | -0.02 | -0.18 | 0.04 | 0.17 | -0.81 | Upgrade
|
| EBT Excluding Unusual Items | 1.69 | -0.41 | -1.19 | -3.63 | 0.76 | -0.18 | Upgrade
|
| Asset Writedown | - | - | 1.67 | -3.09 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.94 | 0.96 | Upgrade
|
| Pretax Income | 1.69 | -0.41 | 0.48 | -6.72 | 1.7 | 0.78 | Upgrade
|
| Income Tax Expense | 1.58 | 0.86 | 0.82 | -0.6 | 0.34 | -0.22 | Upgrade
|
| Net Income | 0.11 | -1.27 | -0.34 | -6.12 | 1.36 | 1 | Upgrade
|
| Net Income to Common | 0.11 | -1.27 | -0.34 | -6.12 | 1.36 | 1 | Upgrade
|
| Net Income Growth | - | - | - | - | 35.97% | - | Upgrade
|
| Shares Outstanding (Basic) | 229 | 188 | 177 | 177 | 177 | 177 | Upgrade
|
| Shares Outstanding (Diluted) | 229 | 188 | 177 | 177 | 177 | 177 | Upgrade
|
| Shares Change (YoY) | 14.75% | 6.26% | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.00 | -0.01 | -0.00 | -0.03 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.01 | -0.00 | -0.03 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | - | - | - | - | 35.97% | - | Upgrade
|
| Free Cash Flow | 4.33 | 0.23 | 1.69 | -0.88 | 2.67 | 1.16 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.00 | 0.01 | -0.01 | 0.01 | 0.01 | Upgrade
|
| Gross Margin | 53.42% | 55.11% | 52.94% | 51.50% | 52.25% | 53.62% | Upgrade
|
| Operating Margin | 5.24% | 1.75% | -0.53% | -7.03% | 2.56% | 2.68% | Upgrade
|
| Profit Margin | 0.19% | -2.48% | -0.67% | -14.26% | 3.52% | 2.79% | Upgrade
|
| Free Cash Flow Margin | 7.40% | 0.46% | 3.36% | -2.04% | 6.92% | 3.25% | Upgrade
|
| EBITDA | 3.52 | 1.4 | 0.24 | -2.6 | 1.5 | 1.48 | Upgrade
|
| EBITDA Margin | 6.02% | 2.74% | 0.47% | -6.05% | 3.89% | 4.13% | Upgrade
|
| D&A For EBITDA | 0.46 | 0.5 | 0.51 | 0.42 | 0.51 | 0.52 | Upgrade
|
| EBIT | 3.06 | 0.9 | -0.27 | -3.02 | 0.99 | 0.96 | Upgrade
|
| EBIT Margin | 5.24% | 1.75% | -0.53% | -7.03% | 2.56% | 2.68% | Upgrade
|
| Effective Tax Rate | 93.31% | - | 170.42% | - | 20.08% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.